Benedetta Di Robilant is a highly accomplished scientific professional with extensive experience in the fields of molecular medicine, stem cell biology, and regenerative medicine. Currently serving as a Scientific Advisor at Multiply Labs since April 2022, Benedetta co-founded Dorian Therapeutics, where the role of Chief Scientific Officer was held until June 2025 following its acquisition by Altos Labs. Benedetta has also contributed to the entrepreneurial ecosystem as a member of StartX and Y Combinator’s bio programs in 2018, and completed a postdoctoral fellowship at Stanford University School of Medicine. Benedetta holds a PhD in Molecular Medicine from Libera Università Vita-Salute San Raffaele, complemented by a robust academic background in medical and pharmaceutical biotechnology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices